| Literature DB >> 24137278 |
Ling-DE Kong1, Ling-Chen Meng, Lin-Feng Wang, Yong Shen, Pan Wang, Zi-Kun Shang.
Abstract
The optimal management approach for patients with mild forms of cervical spondylotic myelopathy (MCSM) has not been well established. The aim of the present study was to investigate the outcome of conservative treatment, identify prognostic factors and provide evidence for the timing of surgical intervention. A total of 90 patients with MCSM attending hospital between February 2007 and January 2009 were prospectively enrolled. Initially, all patients received conservative treatment and were followed up periodically. When a deterioration in myelopathy was clearly identified, surgical treatment was conducted. Clinical and radiological factors correlating with the deterioration were examined, and final clinical outcomes were evaluated using the Japanese Orthopedic Association (JOA) score. At the end of January 2012, follow-ups of >3 years were completed. Seventy-eight patients were available for data analysis. Only 21 patients (26.9%) deteriorated and underwent surgery thereafter (group A), while the remaining 57 patients (73.1%) were treated conservatively throughout (group B). Statistical analysis revealed that segmental instability and cervical spinal stenosis were adverse factors for the prognosis of conservative treatment. Although the JOA scores of the patients in group A declined initially, following surgical intervention, no significant differences were identified in JOA scores between the two groups at the time of the final follow-up (P=0.46). In summary, conservative treatment is effective in MCSM patients. Patients with segmental instability and cervical spinal stenosis have a tendency to deteriorate, but conservative treatment remains the recommendation for the first action. If the myelopathy deteriorates during conservative treatment, timely surgical intervention is effective.Entities:
Keywords: cervical myelopathy; conservative treatment; prognosis; surgical treatment
Year: 2013 PMID: 24137278 PMCID: PMC3786935 DOI: 10.3892/etm.2013.1224
Source DB: PubMed Journal: Exp Ther Med ISSN: 1792-0981 Impact factor: 2.447
Japanese Orthopaedic Association (JOA) scores for assessment of cervical myelopathy.
| Category | Score (points) |
|---|---|
| Motor function of the upper extremity | |
| Unable to eat with either chopsticks or a spoon | 0 |
| Able to eat with a spoon, but not with chopsticks | 1 |
| Able to eat with chopsticks, but inadequately | 2 |
| Able to eat with chopsticks, but awkwardly | 3 |
| Normal | 4 |
| Motor function of the lower extremity | |
| Unable to walk | 0 |
| Needs a cane or other walking aid on flat ground | 1 |
| Needs walking aid only on stairs | 2 |
| Able to walk unaided, but slowly | 3 |
| Normal | 4 |
| Sensory function | |
| Upper extremity | |
| Apparent sensory disturbance | 0 |
| Minimal sensory disturbance | 1 |
| Normal | 2 |
| Lower extremity | |
| Apparent sensory disturbance | 0 |
| Minimal sensory disturbance | 1 |
| Normal | 2 |
| Trunk | |
| Apparent sensory disturbance | 0 |
| Minimal sensory disturbance | 1 |
| Normal | 2 |
| Bladder function | |
| Urinary retention or incontinence | 0 |
| Severe dysuria (sense of retention) | 1 |
| Slight dysuria (pollakiuria, retardation) | 2 |
| Normal | 3 |
The score in a normal subject is the total of the highest scores: (I + II + III + IV) = 17 points.
Figure 1Measurement of diameters of the cerebrospinal fluid (CSF) column and spinal cord compression on T2 sagittal MRI. L1–L4 were diameters of the CSF at the mid-vertebra level from C4 to C7. Diameter of the CSF column (mm) = (L1+L2+L3+L4)/4. a and b are the spinal cord diameters of narrowest part and the C2/3 intervertebral level. Spinal cord compression (%) = a/b.
Figure 2Treatment profile in of patients with mild forms of cervical spondylotic myelopathy (MCSM) in the present study.
Baseline demographic characteristics.
| Variable | Value |
|---|---|
| No. of patients | 78 |
| No. of deteriorated patients | 21 |
| Gender (male:female) | 45:33 |
| Age (years) | 37–71 (57.8) |
| Follow-up period (months) | 36–56 (40.0) |
| JOA scores of initial follow-up | 13–16 (14.1) |
| JOA scores of final follow-up | 10–16 (14.0) |
Values in parentheses are mean values. JOA, Japanese Orthopedic Association.
Risk factors of neurological deterioration.
| Factor | Group A (n=21) | Group B (n=57) | P-value |
|---|---|---|---|
| Age (years) | 58.8±11.3 | 57.5±10.5 | 0.62 |
| Gender (male:female) | 13:8 | 32:25 | 0.80 |
| Duration of disease (months) | 23.3±19.2 | 19.3±15.0 | 0.70 |
| C2–C7 angle (degrees) | 9.9±10.7 | 11.6±10.7 | 0.61 |
| Segmental instability (yes:no) | 9:12 | 8:49 | 0.01 |
| Spinal cord intensity changes (yes:no) | 14:7 | 26:31 | 0.13 |
| Compression-affected levels (no.) | 1.4 | 1.3 | 0.53 |
| Diameter of the CSF column (mm) | 10.7±1.8 | 12.1±1.2 | 0.02 |
| Spinal cord compression (%) | 78.2±6.3 | 75.3±8.1 | 0.19 |
Measurement results are expressed as the mean ± SD. Group A, deterioration after conservative treatment; Group B, no deterioration after conservative treatment; CSF, cerebrospinal fluid.
Figure 3Changes in Japanese Orthopedic Association (JOA) scores.